These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26802653)

  • 1. Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells.
    Choghaei E; Khamisipour G; Falahati M; Naeimi B; Mossahebi-Mohammadi M; Tahmasebi R; Hasanpour M; Shamsian S; Hashemi ZS
    Oncol Res; 2016 Jan; 23(1-2):69-78. PubMed ID: 26802653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.
    Khamisipour G; Mansourabadi E; Naeimi B; Moazzeni A; Tahmasebi R; Hasanpour M; Mohammadi MM; Mansourabadi Z; Shamsian S
    Mol Clin Oncol; 2018 Feb; 8(2):362-369. PubMed ID: 29435304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1.
    Zhao Y; Yang F; Li W; Xu C; Li L; Chen L; Liu Y; Sun P
    Tumour Biol; 2017 Feb; 39(2):1010428317692264. PubMed ID: 28222663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
    Shi Y; Gong W; Lu L; Wang Y; Ren J
    Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
    Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
    Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory role of Mir-29 in growth of breast cancer cells.
    Wu Z; Huang X; Huang X; Zou Q; Guo Y
    J Exp Clin Cancer Res; 2013 Dec; 32(1):98. PubMed ID: 24289849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells.
    Zhang C; Zhao J; Deng H
    Mol Cell Biochem; 2013 Jul; 379(1-2):201-11. PubMed ID: 23568502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
    Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
    Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of docosahexaenoic acid (DHA) and linoleic acid (LA) on miR-101 and miR-342 tumor suppressor microRNAs in Taxol-treated HER2-positive breast cancer cells.
    Aslan C; Maralbashi S; Shekari N; Javadian M; Shomali N; Kazemi T
    Clin Nutr ESPEN; 2024 Oct; 63():502-507. PubMed ID: 39047867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
    Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
    Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.
    Tao WY; Liang XS; Liu Y; Wang CY; Pang D
    Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
    Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT
    Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line.
    Gu X; Li JY; Guo J; Li PS; Zhang WH
    Med Sci Monit; 2015 Oct; 21():3291-7. PubMed ID: 26516138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.
    Mei M; Ren Y; Zhou X; Yuan XB; Han L; Wang GX; Jia Z; Pu PY; Kang CS; Yao Z
    Technol Cancer Res Treat; 2010 Feb; 9(1):77-86. PubMed ID: 20082533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance.
    Yuan LL; Li L; Liu JN; Mei J; Lei CJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.
    Zhou M; Liu Z; Zhao Y; Ding Y; Liu H; Xi Y; Xiong W; Li G; Lu J; Fodstad O; Riker AI; Tan M
    J Biol Chem; 2010 Jul; 285(28):21496-507. PubMed ID: 20460378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.